- BMJ Case Reports corporate subscription

Leading health science journals from BMJ The BMJ One of the most influential and respected general medicine journals in the world. The BMJ features original research, reviews, expert analysis, authoritative opinion and medical education content. Rapid recommendations: Clinical guidance that is updated when new practice-changing evidence becomes available.

Give your teams access to the world's largest collection of clinical case reports.

Case reports are an effective way to monitor drug performance. Far exceeding the limited insights of clinical trials, they provide detailed information on symptoms, diagnosis and treatments of patients in real life situations. BMJ Case Reports is the largest database of clinical case reports with more than 2 7 ,000 cases from over 70 countries. Indexed by all the major bibliographic databases, this award-winning resource will give your drug safety, R&D and marketing teams unrivaled access to a wealth of information on adverse reactions, drug effectiveness and novel uses, with clinically important information on common and rare conditions.

A corporate subscription to BMJ Case Reports provides :

An invaluable resource providing quick information on drug interactions 1,000 + cases on novel treatments (new drug/intervention; established drug/procedure in new situation)

Access to the world's largest online collection of case reports

Dedicated collections focused on pharmacology & therapeutics; contraindications & precautions and drug interactions

To find out how your organi z ation can benefit from a subscription to BMJ Case Reports, please contact 1+ (855 ) 458-0579 North America E: uss ales @bmj.com Latin America & t he Caribbean E: latams ales @bmj.com casereports.bmj.com

Case Reports Corporate subscription 7 /2 4

Page 1

bmjgroup.com

Powered by